Compounds > conivaptan
Page last updated: 2024-09-04

conivaptan and relcovaptan

conivaptan has been researched along with relcovaptan in 7 studies

Compound Research Comparison

Studies
(conivaptan)		Trials
(conivaptan)		Recent Studies (post-2010)
(conivaptan)		Studies
(relcovaptan)		Trials
(relcovaptan)		Recent Studies (post-2010) (relcovaptan)
1881764120940

Protein Interaction Comparison

ProteinTaxonomyconivaptan (IC50)relcovaptan (IC50)
Vasopressin V1a receptorHomo sapiens (human)0.013

Research

Studies (7)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (28.57)18.2507
2000's5 (71.43)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Ishii, N; Kusayama, T; Saito, M; Sugimoto, T; Tahara, A; Tanaka, A; Tomura, Y; Tsukada, J; Uchida, W; Wada, K; Yatsu, T1
Ishii, N; Kusayama, T; Saito, M; Tahara, A; Tanaka, A; Tomura, Y; Tsukada, J; Uchida, W; Wada, K; Yatsu, T1
Abe, K; Furuichi, K; Saito, M; Sugimoto, T; Tahara, A1
Arthus, MF; Bernier, V; Bichet, DG; Bouvier, M; Brouard, R; Debrand, N; Laperrière, A; Lonergan, M; Morello, JP; Salahpour, A; Zarruk, A1
Streefkerk, JO; van Zwieten, PA1
Kamyar, M; Lemmens-Gruber, R1
Haass, M1

Reviews

3 review(s) available for conivaptan and relcovaptan

ArticleYear
Vasopressin receptor antagonists: pharmacological tools and potential therapeutic agents.
    Autonomic & autacoid pharmacology, 2006, Volume: 26, Issue:2

    Topics: Animals; Antidiuretic Hormone Receptor Antagonists; Arginine Vasopressin; Benzazepines; Drug Design; Heart Failure; Hormone Antagonists; Humans; Hypertension; Inappropriate ADH Syndrome; Indoles; Presynaptic Terminals; Pyrrolidines; Receptors, Vasopressin; Renal Artery; Sympathetic Nervous System; Synaptic Transmission; Tolvaptan; Vasoconstriction; Vasoconstrictor Agents

2006
Vasopressin antagonists.
    Cellular and molecular life sciences : CMLS, 2006, Volume: 63, Issue:15

    Topics: Animals; Antidiuretic Hormone Receptor Antagonists; Azepines; Benzamides; Benzazepines; Binding Sites; Cardiovascular Diseases; Clinical Trials as Topic; Hormone Antagonists; Humans; Indoles; Pyrroles; Pyrrolidines; Tolvaptan; Vasopressins; Water-Electrolyte Imbalance

2006
[Vasopressin receptor antagonists and heart failure].
    Therapeutische Umschau. Revue therapeutique, 2009, Volume: 66, Issue:11

    Topics: Administration, Oral; Aged; Antidiuretic Hormone Receptor Antagonists; Azepines; Benzamides; Benzazepines; Controlled Clinical Trials as Topic; Female; Follow-Up Studies; Furosemide; Heart Failure; Hormone Antagonists; Humans; Hyponatremia; Indoles; Male; Morpholines; Platelet Aggregation Inhibitors; Pyrroles; Pyrrolidines; Sodium Potassium Chloride Symporter Inhibitors; Spiro Compounds; Time Factors; Tolvaptan

2009

Other Studies

4 other study(ies) available for conivaptan and relcovaptan

ArticleYear
Pharmacological characterization of the human vasopressin receptor subtypes stably expressed in Chinese hamster ovary cells.
    British journal of pharmacology, 1998, Volume: 125, Issue:7

    Topics: Animals; Benzazepines; Binding, Competitive; Calcium; CHO Cells; Cricetinae; Cyclic AMP; Humans; Indoles; Morpholines; Piperidines; Pyrrolidines; Quinolones; Receptors, Vasopressin; Spiro Compounds; Transfection; Tritium

1998
Vasopressin increases vascular endothelial growth factor secretion from human vascular smooth muscle cells.
    European journal of pharmacology, 1999, Feb-26, Volume: 368, Issue:1

    Topics: Antidiuretic Hormone Receptor Antagonists; Benzazepines; Cell Line; Dose-Response Relationship, Drug; Endothelial Growth Factors; Humans; Indoles; Lymphokines; Morpholines; Muscle, Smooth, Vascular; Pyrrolidines; Spiro Compounds; Time Factors; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factors; Vasoconstrictor Agents; Vasopressins

1999
Evidence that atypical vasopressin V(2) receptor in inner medulla of kidney is V(1B) receptor.
    European journal of pharmacology, 2000, Aug-11, Volume: 401, Issue:3

    Topics: Animals; Benzazepines; Calcium; CHO Cells; Cricetinae; Deamino Arginine Vasopressin; Dose-Response Relationship, Drug; Humans; Indoles; Inositol Phosphates; Kidney Medulla; Morpholines; Pyrrolidines; Rats; Receptors, Vasopressin; Renal Agents; RNA, Messenger; Spiro Compounds; Vasopressins

2000
Pharmacologic chaperones as a potential treatment for X-linked nephrogenic diabetes insipidus.
    Journal of the American Society of Nephrology : JASN, 2006, Volume: 17, Issue:1

    Topics: Adult; Antidiuretic Hormone Receptor Antagonists; Benzazepines; Cells, Cultured; Chromosomes, Human, X; Diabetes Insipidus, Nephrogenic; Genetic Linkage; Humans; Indoles; Male; Mutation; Pyrrolidines; Receptors, Vasopressin

2006